Related Experiment Video
Updated: Jun 10, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Oral ulcer associated with alendronate: a case report
Mohammad Kharazmi1, Kerstin Sjöqvist, Milad Rizk
1Department of Oral and Maxillofacial Surgery, Central Hospital, Västerås, Sweden.
Alendronate can irritate the aerodigestive tract. This study details the first case of severe oral ulceration caused by alendronate, even when used correctly, highlighting a rare but serious adverse effect.
Area of Science:
- Gastroenterology
- Pharmacology
- Oral Medicine
Background:
- Alendronate is a bisphosphonate commonly prescribed for osteoporosis.
- Aerodigestive tract irritation is a known side effect of alendronate.
- Oral ulceration linked to alendronate is rare, with previous reports primarily associated with drug misuse.
Observation:
- This report presents a case of severe oral ulceration.
- The ulceration occurred despite appropriate therapeutic administration of alendronate.
- This contrasts with the established association between alendronate misuse and oral ulceration.
Findings:
- Alendronate use, even without misuse, can lead to severe oral ulceration.
- This represents the first documented case of oral ulceration attributed to correct alendronate use.
- The mechanism underlying this specific adverse effect requires further investigation.
Implications:
- Clinicians should be aware of the potential for severe oral ulceration as an adverse effect of alendronate, irrespective of administration method.
- This finding may necessitate revised patient counseling and monitoring protocols for alendronate therapy.
- Further research is warranted to elucidate the pathophysiology and identify risk factors for alendronate-induced oral ulceration.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...